Yazar "Dalkilic, E." seçeneğine göre listele
Listeleniyor 1 - 8 / 8
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe BIOSIMILAR INFLIXIMAB EXPERIENCE IN SPONDYLOARTRITIS PATIENTS: TREASURE REAL LIFE RESULTS(Bmj Publishing Group, 2020) Bilge, N. S. Yasar; Kasifoglu, T.; Kiraz, S.; Ertenli, A. I.; Dalkilic, E.; Bes, C.; Emmungil, H.[Abstract Not Available]Öğe DOSE ESCALATION AND SWITCHING PATTERNS OF ANTI-TNF DRUGS IN RHEUMATOID ARTHRITIS: A RETROSPECTIVE CHART - REVIEW STUDY IN TURKEY(Bmj Publishing Group, 2015) Kalyoncu, U.; Aydin, S. Z.; Dalkilic, E.; Kasifoglu, T.; Kisacik, B.; Pamuk, O. N.; Yilmaz, S.[Abstract Not Available]Öğe THE IMPACT OF 6-MONTH DELAY IN DIAGNOSIS ON CLINICAL AND FUNCTIONAL STATUS IN THE PSA PATIENTS UNDER BDMARD TREATMENT: RESULTS FROM TREASURE DATABASE(Bmj Publishing Group, 2023) Ayan, G.; Kilic, L.; Bilge, N. S. Yasar; Atagunduz, P.; Dalkilic, E.; Pehlivan, Y.; Kucuksahin, O.[Abstract Not Available]Öğe Impact of rheumatoid arthritis in Turkey: a questionnaire study(Clinical & Exper Rheumatology, 2014) Direskeneli, H.; Akkoc, N.; Bes, C.; Cakir, N.; Cefle, A.; Cobankara, V.; Dalkilic, E.Objective Unmet needs of rheumatoid arthritis (RA) patients regarding physician/patient communication, treatment preferences and quality of life issues were investigated in a Turkish survey study. Methods The study was conducted with the contribution of 33 rheumatologists, and included 519 RA patients. The study population included patients who had been on biologic therapy for >6 months and were still receiving biologic therapy (BT group), and those who were biologic naive, but found eligible for biologic treatment (NBT group). Of the RA patients, 35.5% initially had a visit to an internal disease specialist, 25.5% to a physical therapy and rehabilitation specialist, and 12.2% to a rheumatology specialist for their RA complaints. The diagnosis of RA was made by a rheumatologist in 48.2% of patients. Results The majority of RA patients (86.3%) visit their doctor within 15-week intervals. Most of the physician-patient communication focused on disease symptoms (99.0%) and impact of the disease on quality of life (61.8%). The proportion of RA patients who perceived their health status as good/very good/excellent was higher in the BT group than in the NBT group (74.3% vs. 51.5%, p<0.001). However, of those RA patients in the NBT group, only 24.8% have been recommended to start a biologic treatment by their doctors. With respect to dose frequency options, once-monthly injections were preferred (80%) to a bi-weekly injection schedule (8%). Conclusion In conclusion, RA patients receiving biologic therapy reported higher rates of improved symptoms and better quality of life and seemed to be more satisfied with their treatment in our study.Öğe PARADOXICAL REACTIONS, ESPECIALLY PSORIASIS IN RHEUMATOLOGY PATIENTS RECEIVING BIOLOGIC THERAPY FROM THE TREASURE DATABASE: A 5-YEAR FOLLOW-UP STUDY(Bmj Publishing Group, 2022) Yagiz, B.; Lermi, N.; Coskun, B. N.; Dalkilic, E.; Kiraz, S.; Ertenli, A. I.; Bilgin, E.[Abstract Not Available]Öğe PARANEOPLASTIC ARTHRITIS: A MULTI-CENTERED EXPERIENCE(Bmj Publishing Group, 2013) Kisacik, B.; Onat, A. M.; Kasifoglu, T.; Pehlivan, Y.; Pamuk, O. N.; Dalkilic, E.; Donmez, S.[Abstract Not Available]Öğe RADIOGRAPHIC VERSUS NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: RESULTS FROM TREASURE DATABASE(Bmj Publishing Group, 2023) Kilic, L.; Ayan, G.; Atagunduz, P.; Akar, S.; Bilge, N. S. Yasar; Dalkilic, E.; Pehlivan, Y.[Abstract Not Available]Öğe THE TRANSITION FROM ACTIVE LESIONS TO STRUCTURAL CHANGES ON SACROILIAC MRI AND ITS ASSOCIATED FACTORS(Bmj Publishing Group, 2023) Kalyoncu, U.; Ayan, G.; Kilic, L.; Atagunduz, P.; Akar, S.; Bilge, N. S. Yasar; Dalkilic, E.[Abstract Not Available]
